Literature DB >> 22054146

Epidemiology and economic impact of obesity and type 2 diabetes.

Hazem Shamseddeen1, Jorge Zelada Getty, Isam N Hamdallah, Mohamed R Ali.   

Abstract

Obesity has become a major public health concern in the United States and the rest of the world. This disease carries significant health risks that encompass several organ systems. Type 2 diabetes mellitus is a major comorbidity of obesity that predisposes patients to significant end-organ damage. The prevalence of obesity and diabetes is increasing worldwide, and the economic impact of these diseases currently assumes a significant portion of health care expenditure. These factors mandate implementation of therapeutic medical and surgical strategies that target prevention and treatment of obesity and its related medical conditions. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22054146     DOI: 10.1016/j.suc.2011.08.001

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  34 in total

1.  Comparison of laparoscopic Roux-en-Y gastric bypass with laparoscopic sleeve gastrectomy for morbid obesity or type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.

Authors:  Jian-Fang Li; Dan-Dan Lai; Bin Ni; Kuan-Xue Sun
Journal:  Can J Surg       Date:  2013-12       Impact factor: 2.089

Review 2.  Prion-Like Protein Aggregates and Type 2 Diabetes.

Authors:  Abhisek Mukherjee; Claudio Soto
Journal:  Cold Spring Harb Perspect Med       Date:  2017-05-01       Impact factor: 6.915

3.  A comparison of D2 receptor specific binding in obese and normal-weight individuals using PET with (N-[(11)C]methyl)benperidol.

Authors:  Sarah A Eisenstein; Jo Ann V Antenor-Dorsey; Danuta M Gredysa; Jonathan M Koller; Emily C Bihun; Samantha A Ranck; Ana Maria Arbeláez; Samuel Klein; Joel S Perlmutter; Stephen M Moerlein; Kevin J Black; Tamara Hershey
Journal:  Synapse       Date:  2013-05-30       Impact factor: 2.562

Review 4.  Autophagy, myocardial protection, and the metabolic syndrome.

Authors:  Zoltan Giricz; Robert M Mentzer; Roberta A Gottlieb
Journal:  J Cardiovasc Pharmacol       Date:  2012-08       Impact factor: 3.105

5.  Distinct temporal phases of microvascular rarefaction in skeletal muscle of obese Zucker rats.

Authors:  Jefferson C Frisbee; Adam G Goodwill; Stephanie J Frisbee; Joshua T Butcher; Robert W Brock; I Mark Olfert; Evan R DeVallance; Paul D Chantler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-10-10       Impact factor: 4.733

Review 6.  Amylin-mediated control of glycemia, energy balance, and cognition.

Authors:  Elizabeth G Mietlicki-Baase
Journal:  Physiol Behav       Date:  2016-02-27

7.  Relation of type 2 diabetes mellitus with gender, education, and marital status in an Iranian urban population.

Authors:  Karamatollah Rahmanian; Mohammad Shojaei; Abdolreza Sotoodeh Jahromi
Journal:  Rep Biochem Mol Biol       Date:  2013-04

Review 8.  Chemerin: a potential endocrine link between obesity and type 2 diabetes.

Authors:  Alexandra A Roman; Sebastian D Parlee; Christopher J Sinal
Journal:  Endocrine       Date:  2012-05-19       Impact factor: 3.633

9.  Fatty acid-binding protein 4 and incident heart failure: the Cardiovascular Health Study.

Authors:  Luc Djoussé; Traci M Bartz; Joachim H Ix; Jinesh Kochar; Jorge R Kizer; John S Gottdiener; Russell P Tracy; Dariush Mozaffarian; David S Siscovick; Kenneth J Mukamal; Susan J Zieman
Journal:  Eur J Heart Fail       Date:  2012-12-06       Impact factor: 15.534

10.  Molecular analysis of gut microbiota in obesity among Indian individuals.

Authors:  Deepak P Patil; Dhiraj P Dhotre; Sachin G Chavan; Armiya Sultan; Dhawal S Jain; Vikram B Lanjekar; Jayshree Gangawani; Poonam S Shah; Jayshree S Todkar; Shashank Shah; Dilip R Ranade; Milind S Patole; Yogesh S Shouche
Journal:  J Biosci       Date:  2012-09       Impact factor: 1.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.